Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Acquisitions - Schedule of Revenue and Earnings of Clarient (Detail)

v3.10.0.1
Acquisitions - Schedule of Revenue and Earnings of Clarient (Detail) - Genoptix
$ in Thousands
3 Months Ended
Dec. 31, 2018
USD ($)
Business Acquisition [Line Items]  
Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual $ 4,629
Business Combination Pro Forma Information Gross Margin Of Acquiree Since Acquisition Date Actual 2,600
Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual $ (334)